Chemokines are low-molecular weight proteins that play a key role in inflammatory processes. Genomic variations in chemokine receptors are associated with the susceptibility to various diseases. Polymorphisms in chemokine receptor type 5 (CCR5)-D32 and CCR2-V64I are related to human immunodeficiency virus infection resistance, which has led to genetic association studies for several other diseases. Given the heterogeneous distribution of these polymorphisms in different global populations and within Brazilian populations, we analyzed the prevalence of CCR5-D32 and CCR2-V64I polymorphisms in a mixed population from northeastern Brazil. The study included 223 individuals from the general population of the city of Parnaíba, Piauí, who had a mean age of 73 years. Of these individuals, 37.2% were men CCR5-D32 and CCR2-V64I polymorphisms in Piauí, Brazil ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 14 (4): 11710-11718 (2015) and 62.8% were women. Polymorphisms were analyzed using DNA extracted from peripheral blood leukocytes by using polymerase chain reaction alone (CCR5-D32) or accompanied by restriction endonuclease digestion (CCR2-V64I). In both cases, the genotypes were determined using 8% polyacrylamide gel electrophoresis and silver nitrate staining. The population conformed to Hardy-Weinberg equilibrium for both the loci studied. No individuals were homozygous for allele-D32, which was present in 1.8% of the population, whereas allele-64I was present in 13.9% of the participants studied; 74.9% were homozygous for the wild-type allele, while 22.4 and 2.7% were heterozygous and homozygous for the mutant allele, respectively. Additional studies are needed to investigate the relationship between these polymorphisms and disease etiopathogenesis in reference populations.
INTRODUCTION
Chemokines are low-molecular weight proteins that, in general, mediate the migration of immune cells during inflammatory responses (Griffith et al., 2014) . To drive the migration of these cells during inflammation, chemokines interact with G protein-coupled 7-transmembrane domain receptors that are differentially expressed on the surfaces of several cell types. Chemokine receptor 5 (CCR5), which recognizes CCL5, CCL3, CCL4, and CCL8 chemokine ligands, is encoded by the CCR5 gene located on 3p21 and forms a cluster with other chemokine receptor genes. This cluster includes CCR2, which encodes the receptor for CCL2, CCL8, CCL7, and CCL13 (Soto-Sánchez et al., 2010; Griffith et al., 2014) .
Many recent studies have shown that the susceptibility of an individual to infectious and inflammatory diseases can be modulated by genomic variations in chemokine receptors (Guergnon and Combadière, 2012) . The strongest evidence comes from studies of the CCR5-Δ32 (rs333) polymorphism, a 32-bp deletion in the CCR5 coding region that introduces a premature stop codon and results in the production of a nonfunctional receptor . In 1996, Deng et al. showed that CCR5 acts as a co-receptor for human immunodeficiency virus type 1 (HIV-1), and Huang et al. (1996) subsequently found that D32/D32 individuals are generally protected from HIV-1 infection.
Other chemokine receptor gene polymorphisms may not directly affect the susceptibility of individuals to a disease, but may affect their clinical outcomes. CCR2-V64I (rs1799864) polymorphism, in which adenine is substituted for guanine at CCR2 position 190, changes the amino acid valine (V) to isoleucine (I) at position 64 within the first transmembrane domain of the protein (Rabkin et al., 1999) . Although CCR2-V64I polymorphism does not influence HIV-1 transmissibility, studies have shown that patients carrying the mutant 64I allele have better prognoses when infected with this virus (Mahajan et al., 2010; Ammaranond et al., 2013) .
Since their initial characterization, CCR5-D32 and CCR2-V64I polymorphisms have become attractive candidates for genetic association studies of various diseases, particularly those examining the circulatory system and neoplasms (Jones et al., 2011; Lin et al., 2012; Kucukgergin et al., 2012; Tanyel et al., 2013; Zambra et al., 2013) . However, for complex diseases, the actual clinical relevance of these polymorphisms remains inconclusive and studies have shown conflicting results (Vázquez-Lavista et al., 2009; Kucukgergin et al., 2012) . The genetic variability of different populations worldwide may help explain the discrepancies observed in these studies, which reinforces the need for validation of studies in different populations.
CCR5-D32 polymorphism is highly prevalent in individuals of European descent and virtually nonexistent in African, Asian, and Native American populations, strongly suggesting that the allele-D32 originated from a single mutational event in northern Europe a few thousand years ago (Novembre et al., 2005) . In contrast, the CCR2-V64I polymorphism is relatively common in different populations and ethnic groups worldwide (De Pinho Lott Carvalhaes et al., 2004; Zafiropoulos et al., 2004; Qian et al., 2008; Zapata et al., 2013) .
The Brazilian population is one of the most racially mixed in the world. Recently, Lopes et al. (2014) evaluated the ancestry and genetic distance of the population residing in the Piauí State in northeastern Brazil using 46 informative markers of ancestry. The population of this state comprised 60% European, 21.5% African, and 18.5% indigenous peoples. The distribution of CCR5-D32 and CCR2-64I polymorphisms has been studied in different regions in Brazil (Acosta et al., 2003; De Pinho Lott Carvalhaes et al., 2004; Boldt et al., 2009 ); however, the frequencies of these polymorphisms in Piauí have not been reported. Therefore, in this study, we analyzed the prevalence of the CCR5-D32 and CCR2-V64I polymorphisms in a sample population in the State of Piauí and compared their frequencies to those observed in Brazil and other countries.
MATERIAL AND METHODS

Study population and DNA extraction
We analyzed a sample population representing the general population of the city of Parnaíba, Piauí, Brazil (02°54′18ʺ S; 41°46′37ʺ W). The sample population included 223 elderly individuals recruited from the largest project on frailty in the elderly population in Brazil -the Network of Research on Frailty in Elderly Brazilians. All volunteers were informed of the purpose of the study and the experimental procedures. All the participating individuals signed an informed consent statement. The study was approved by the Universidade Fed eral do Piauí Ethics Committee in Research. Peripheral blood samples (4 mL) were collected from each subject, from which leukocyte DNA was extracted using the Wizard ® Genomic DNA Purification kit (Promega, Madison, WI, USA) according to the manufacturer instructions.
Genotyping
The polymorphisms CCR2-V64I and CCR5-D32I were detected in the DNA samples using polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism analysis. The sequence of the primers and interpretation of the genotypes are shown in Table  1 . The 25-mL reaction contained 50 ng DNA, 0.4 mM of each primer, 0.2 mM dNTPs, 1.5 mM MgCl 2 , 1.5 U Taq DNA polymerase, and distilled Milli-Q H 2 O. The PCR cycling parameters, optimized for both polymorphisms, were as follows: initial denaturation at 95°C for 5 min; followed by 35 cycles at 95°C for 45 s, 58°C for 45 s, and 72°C for 45 s; and a final extension step at 72°C for 7 min. To analyze the CCR2-V64I polymorphism, the PCR product was digested with BsaBI restriction endonuclease (New England Biolabs, Ipswich, MA, USA) according to the manufacturer recommendations. The PCR products (CCR5-D32) and digestion fragments (CCR2-V64I) were visualized after separation by 8% polyacrylamide gel electrophoresis and staining with silver nitrate. To detect possible contamination, a blank PCR (no DNA template) was performed as a negative control. As an internal control of enzymatic activity, a 347-bp PCR product of SCN5A exon 15, which contains a known BsaBI cleavage site, was digested with each set of reactions. Finally, 5% of samples were randomly selected for repeat analysis in order to ensure the reliability of the results.
Statistical analysis
Genotypic and allelic frequencies were determined by simple counting. To test whether the population was in Hardy-Weinberg equilibrium, genotype frequencies were first calculated from allele frequencies, and then their deviation from the number of observed genotypes was determined using c² tests. The Fisher exact test was used to compare allele frequencies found in this study with those observed in other populations. The level of significance was set to 5%. For statistical evaluation, the BioEstat version 5.0 software was used.
RESULTS
The study participants (N = 223) included elderly individuals aged 65-93 years (mean 73 ± 4.90 years). Of these participants, 37.2% were males and 62.8% were females. Allele and genotype frequencies of the 2 loci investigated are presented in Table 2 . The genotype frequencies of the 2 polymorphisms analyzed were in Hardy-Weinberg equilibrium (CCR5-D32: c² = 0.074, P = 0.785; CCR2-V64I: c² = 0.895, P = 0.344). The allele-D32 frequency was 1.8%; 8 of the 223 study participants (3.6%) were heterozygous (wt/D32), whereas no participants were homozygous (D32/D32). In contrast, 50 (22.4%) and 6 (2.7%) of the 223 participants studied were heterozygous (wt/64I) and homozygous (64I/64I) for the CCR2-V64I polymorphism, respectively, corresponding to an allele frequency of 13.9%. No statistically significant differences were observed in the distribution of either polymorphism according to gender and age (P > 0.05).
DISCUSSION
The Brazilian population is characterized by significant genetic diversity, which is the result of a rich history of miscegenation, mainly among European, African, and native Amerindian populations. Therefore, the distribution of genomic variants in the general Brazilian population does not show a consistent pattern, as is observed in other countries whose populations are predominantly Caucasian, African, or Asian (Qian et al., 2008; Barmania et al., 2013; Zwolińska et al., 2013) . Therefore, each Brazilian state should be studied to clarify the distribution of genetic polymorphisms that are relevant to public health. In this study, we report the distribution of the CCR5-D32 and CCR2-V64I polymorphisms in the State of Piauí, located in northeastern Brazil. Such polymorphisms are associated with HIV infection resistance and, as such, have been targets of many genetic association studies for several diseases.
The frequency of allele-D32 in the mixed population in this study was 1.8%, which is not significantly different from the observed frequency in the general population in other regions of Brazil, which is 3-6% (Table 3) . However, when the analysis was stratified according to ethnic groups in the population, the frequency of allele-D32 varied from 0-9%. Remarkably, allele-D32 was more frequently found in individuals of European descent in southern Brazil. Boldt et al. (2009) analyzed the distribution of this polymorphism in different ethnic groups residing in the State of Paraná in southern Brazil and found a frequency of 9.3% in a sample of 172 Euro-Brazilian individuals, which was significantly different from the population in this study (P < 0.05). Moreover, the frequency of this allele increased to 14.2% in a group of 53 Euro-Brazilian individuals whose ancestors were from or joined Mennonite settlements in southern Brazil (data not shown). In contrast, the frequency of allele-D32 in the African-Brazilian population ranges from 0.7-2.0% and is rarely observed in Indian tribes (Table 3 ). Additionally, one study reported a frequency of 0% in Japanese immigrants living in the State of Pará in northern Brazil (De Pinho Lott Carvalhaes et al., 2004) .
Globally, the CCR5-D32 polymorphism is more prevalent in European countries and is found in 3-12% of the healthy population (Table 4 ). Although this value was lower, the frequency of allele-D32 in this study (1.8%) did not differ from that reported in some European countries, including Greece (3.3%) and Sweden (6%) (P > 0.05) (Zafiropoulos et al., 2004; Zheng et al., 2006) . However, allele-D32 is present at a significantly higher frequency in countries such as Spain (9.4%) and Poland (12.1%) (P < 0.05) (Soto-Sánchez et al., 2010; Zwolińska et al., 2013) . In Portugal, one of the countries that has most significantly influenced the genetic background of the Brazilian population, a frequency of 8% was reported for the general population, which is at the limit of statistical significance when compared with the frequency observed in this study (P = 0.05) (Carvalho et al., 2014) . In Middle Eastern countries, variation in the allele-D32 frequency was more apparent, ranging from 0.6-14%, with the highest frequencies found in Turkey (9.1%) and Israel (14.3 %) (P < 0.05) (Martinson et al., 2000; Khabour et al., 2013; Tanyel et al., 2013) . In contrast, allele-D32 is rarely seen in Asian and African countries (Table 4 ). Finally, the frequency of the CCR5-D32 polymorphism in Latin American countries ranged from 0%, as observed in a Haitian population (Martinson et al., 2000) , to 3.9%, a frequency reported in Argentina (Mangano et al., 2000) .
While the CCR5-D32 polymorphism exhibits a relatively restricted distribution, the CCR2-V64I polymorphism is distributed globally and appears to be common in all ethnic groups studied, indicating that allele-64I is much older than D32 (Martinson et al., 2000) . In the present study, the frequency of the CCR2-V64I polymorphism observed in a population from northeastern Brazil was 13.9%, which is consistent with the observed frequencies in other world populations, particularly in European countries and the Middle East (Table 4 ). The frequency of this polymorphism is comparatively high in some Asian countries such as Japan and South Korea, where allele-64I shows frequencies of approximately 23 and 30%, respectively (Miyagishi et al., 2003; Kim et al., 2007) . However, Qian et al. (2008) assessed the frequency of allele-64I in 1036 Chinese individuals belonging to different ethnicities and found that the frequency of allele-64I ranged from 2-28% according to ethnicity, with an average frequency of 13.8%. Furthermore, in a Taiwanese population, a frequency of 14.4% for allele-64I was reported, which is consistent with the population observed in this study (P > 0.05) (Lin et al., 2012) . Our results were also consistent with those observed in African and some American populations, although the frequency of allele-64I in these populations is relatively higher, as observed in Cameroon (19.9%), Colombia (23.2%), and Mexico (24.2%) (P > 0.05) Vázquez-Lavista et al., 2009; Zapata et al., 2013) . ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 14 (4): 11710-11718 (2015) Within the Brazilian territory, the frequency of the CCR2-V64I polymorphism observed in the Piauí population was similar to that reported for the general population in other states as well as in European subpopulations or in individuals of African descent (Acosta et al., 2003; De Pinho Lott Carvalhaes et al., 2004; Vargas et al., 2005; Zambra et al., 2013) . Notably, the observed frequency in indigenous tribes in northern Brazil may be as high as 30%, a significantly higher frequency than that observed in this study (P < 0.05) (Acosta et al., 2003) . The frequency reported in a population of Japanese immigrants was 24% (P = 0.05) (De Pinho Lott Carvalhaes et al., 2004) .
CONCLUSIONS
In conclusion, our results did not differ from those reported for other Brazilian admixed populations. Moreover, the high frequency of the CCR5-D32 and CCR2-V64I polymorphisms observed in certain ethnic populations reflected the high level of genetic heterogeneity in the Brazilian population. In addition to the well-documented relationship between these polymorphisms and the susceptibility to HIV infection, studies have revealed an association between these polymorphisms and diseases such as cancer and cardiovascular disease. Therefore, further studies on this population are required to determine how these polymorphisms modulate the clinical course of these diseases.
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